Header image
yellowbar
 

Care & Treatment Committee

**Looking for the Oral Health Care Workgroup? Scroll down this page to find the workgroup’s agendas and meeting minutes.

Who We Are

  • Chair: Frederick Downs, Jr.
  • Chair elect: Thomas Jardon

Our members are people living with HIV/AIDS, care givers, Ryan White Program service providers, government representatives and community members. Our vision is to eliminate disparities and improve health outcomes for all people living with or at risk for HIV/AIDS.
 

What We Do

On July 13, 2015, the Miami-Dade HIV/AIDS Partnership (the Partnership) appointed the Care and Treatment Committee to establish a 12-month workgroup that will address retention in care issues in conjunction with Behavioral Science Research Corporation.  The workgroup will be composed of seven voting members, will follow parameters developed by Behavioral Science Research Corporation, and will be subject to ratification by the Partnership.

All suggestions and feedback from, and work of, the workgroup must be presented first to the Care and Treatment Committee for review, and then to the Partnership for approval.

Committee Responsibilities

  • Develop and implement care and treatment planning
  • Conduct an annual comprehensive needs assessment
  • Determine Ryan White Program (Part A/MAI) service priorities
  • Allocate Ryan White Program (Part A/MAI) funds each fiscal year
  • Develop directives based on identified access issues to underserved populations and areas of greatest need
  • Evaluate service cost and utilization of Partnership programs as a whole
  • Identify funding and provider resources within Miami-Dade County
  • Make recommended appointments to the Florida Comprehensive Planning Network’s (FCPN) Patient Care Planning Group (PCPG)

 

 

 

 

 

 

 

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number H89HA00005, CFDA #93.914 - HIV Emergency Relief Project Grants, for $26,483,857, of which 0% was financed with nongovernmental sources.  This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.

 
yellowbar